Depression is common in older adults and those with cardiovascular disease. Although
selective serotonin reuptake inhibitors generally have been shown to be safe to treat …

Newer antidepressants that are more selective in their neurotransmitter effects include the
selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors …

BACKGROUND Major depression or deterioration of previous mood disorders is a common
adverse consequence of coronary heart disease, heart failure, and cardiac revascularization …

Objective: To review data examining the relationships between depression, antidepressants
and cardiovascular disease. Method: Structured searches of PubMed, Medline and Embase …

It has long been evident that the tricyclic antidepressants have serious cardiovascular
effects. This becomes an increasingly important issue as patient populations age. In …

There is a definite correlation between cardiovascular diseases and depressive disorders.
Nevertheless, many aspects of this association have yet to be fully elucidated. Up to half of …

Objective: To examine whether selective serotonin reuptake inhibitor (SSRI) antidepressants
were associated with an increased or decreased risk of cardiovascular adverse events …

The cardiovascular toxicity of older generation of tricyclic antidepressants (eg imipramine,
desipramine, amitriptyline, clomipramine) and neuroleptics (eg haloperidol, droperidol …

Introduction: Antidepressants (ADs) are widely used among elderly persons, making AD-
related safety an important issue. Areas covered: This review highlights safety …

There is convincing evidence that depression can significantly and adversely affect
cardiovascular health and increase mortality rates in patients with documented ischemic …